Literature DB >> 25939072

Doubt, defiance, and identity: Understanding resistance to male circumcision for HIV prevention in Malawi.

Justin O Parkhurst1, David Chilongozi2, Eleanor Hutchinson3.   

Abstract

Global policy recommendations to scale up of male circumcision (MC) for HIV prevention tend to frame the procedure as a simple and efficacious public health intervention. However, there has been variable uptake of MC in countries with significant HIV epidemics. Kenya, for example, has embraced MC and has been dubbed a 'leader' by the global health community, while Malawi has been branded a 'laggard' in its slow adoption of a national programme, with a strong political discourse of resistance forming around MC. Regardless of any epidemiological or technical evidence, the uptake of international recommendations will be shaped by how a policy, and the specific artefacts that constitute that policy, intersect with local concerns. MC holds particular significance within many ethnic and religious groups, serving as an important rite of passage, but also designating otherness or enabling the identification of the social and political self. Understanding how the artefact of MC intersects with local social, economic, and political contexts, is therefore essential to understand the acceptance or resistance of global policy recommendations. In this paper we present an in-depth analysis of Malawi's political resistance to MC, finding that ethnic and religious divisions dominating recent political movements aligned well with differing circumcision practices. Political resistance was further found to manifest through two key narratives: a 'narrative of defiance' around the need to resist donor manipulation, and a 'narrative of doubt' which seized on a piece of epidemiological evidence to refute global claims of efficacy. Further, we found that discussions over MC served as an additional arena through which ethnic identities and claims to power could themselves be negotiated, and therefore used to support claims of political legitimacy.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Evidence and policy; HIV; Malawi; Male circumcision; Policy transfer

Mesh:

Year:  2015        PMID: 25939072     DOI: 10.1016/j.socscimed.2015.04.020

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  5 in total

1.  Educating religious leaders to create demand for medical male circumcision.

Authors:  Nelson K Sewankambo; David K Mafigiri
Journal:  Lancet       Date:  2017-02-15       Impact factor: 79.321

2.  Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.

Authors:  Jennifer A Downs; Agrey H Mwakisole; Alphonce B Chandika; Shibide Lugoba; Rehema Kassim; Evarist Laizer; Kinanga A Magambo; Myung Hee Lee; Samuel E Kalluvya; David J Downs; Daniel W Fitzgerald
Journal:  Lancet       Date:  2017-02-15       Impact factor: 79.321

3.  Acceptability and feasibility of early infant male circumcision for HIV prevention in Malawi.

Authors:  Charles Chilimampunga; Simeon Lijenje; Judith Sherman; Kelvin Nindi; Webster Mavhu
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

4.  How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan.

Authors:  Mishal S Khan; Ankita Meghani; Marco Liverani; Imara Roychowdhury; Justin Parkhurst
Journal:  Health Policy Plan       Date:  2018-03-01       Impact factor: 3.344

Review 5.  Lenses and levels: the why, what and how of measuring health system drivers of women's, children's and adolescents' health with a governance focus.

Authors:  Asha George; Amnesty Elizabeth LeFevre; Tanya Jacobs; Mary Kinney; Kent Buse; Mickey Chopra; Bernadette Daelmans; Annie Haakenstad; Luis Huicho; Rajat Khosla; Kumanan Rasanathan; David Sanders; Neha S Singh; Nicki Tiffin; Rajani Ved; Shehla Abbas Zaidi; Helen Schneider
Journal:  BMJ Glob Health       Date:  2019-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.